VidofludimusVidofludimus
Move your mouse over image or click to enlarge

Vidofludimus

Vidofludimus (SC12267, 4SC-101) is an orally active and potent dihydroorotate dehydrogenase (DHODH) inhibitor with IC50 of 134 nM for human DHODH. Vidofludimus calcium (IMU-838) is investigated as a potential treatment option for COVID-19. Phase 2.
Cat# Size Price Qty Buy
S7262-25mg 25mg
£407.00
S7262-5mg 5mg
£120.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# S7262

Related Documents